APA (7th ed.) Citation

LR, F., A, B., L, G., R, W., J, R., TM, B., . . . AL, N. (2024). Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years. JAMA, 331(5), 408. https://doi.org/10.1001/jama.2023.27022

Chicago Style (17th ed.) Citation

LR, Feldstein, et al. "Effectiveness of Bivalent MRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years." JAMA 331, no. 5 (2024): 408. https://doi.org/10.1001/jama.2023.27022.

MLA (9th ed.) Citation

LR, Feldstein, et al. "Effectiveness of Bivalent MRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years." JAMA, vol. 331, no. 5, 2024, p. 408, https://doi.org/10.1001/jama.2023.27022.